C4 Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.25
0.15
(13.64%)
Volume:
1,772,621
52 week range:
1.09 - 7.66
Market Cap:
88.737M
Company Description:
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting multiple myeloma and non-Hodgkin lymphomas. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.